ArticleWater Reuse2026
Perspectives on next-generation secondary wastewater treatment for potable reuse applications.
Article in Water Reuse, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The growing implementation of indirect and direct potable reuse (IPR and DPR) highlights the need for robust wastewater treatment to strengthen the performance and reliability of downstream advanced water purification facilities (AWPFs). Next-generation secondary waste-water treatment processes are now being considered to enhance compatibility in potable reuse schemes. This perspective analyzes the role of competing next-generation biotechnologies such as integrated fixed-film activated sludge (IFAS) and the moving bed biofilm reactor (MBBR), membrane biofilm reactor (MBfR), Modified Ludzack-Ettinger membrane bioreactor (MLE-MBR) and anaerobic membrane bioreactor (AnMBR) upstream of reverse osmosis (RO)- and activated carbon (AC)-based AWP, and their ability to enhance contaminant removal and improve overall efficiency of AWP. Both MLE-MBR and AnMBR significantly enhance the removal of suspended solids, organics, and microbial contaminants through membrane filtration. AnMBR offers the possibility of net energy-positive operation but does not remove nitrogen, limiting compatibility with AWP. MLE-MBR removes nitrogen but has significantly greater energy demand due to aeration and mixed liquor return pumping. Overall, next-generation biotechnologies provide flexible and effective solutions to enhance secondary effluent quality, supporting safe and regulation-compliant IPR and DPR applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.